Cashu | News | LSTA

HomeWatchlistNewsSignalsPicks

DJI

+0.03%

SPX

+0.17%

IXIC

+0.55%

FTSE

+0.14%

N225

+1.45%

AXJO

-0.24%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Lisata Therapeutics News

Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration

Feature Image for interests on Biotechnology, Contracts, Energy, Health Care & Hospitals from prnewswire.com

about 5 hours ago

Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views

Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Consumer Cyclical, Fda Approval from prnewswire.com

Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal

Feature Image for interests on Biotech, Contracts, Health Care, Healthcare from benzinga.com

Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease

Feature Image for interests on Biotechnology, Energy, Health Care & Hospitals, Healthcare from prnewswire.com

IDEAYA Biosciences Announces IND Submission for IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deletion Solid Tumors

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Licensing from prnewswire.com

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Imbed Biosciences Launches Dual-Action Wound Matrix Integrating Bioburden Management and Pain Relief in a Single Solution

Feature Image for interests on Health Care & Hospitals, Healthcare, Medical Pharmaceuticals, New Products & Services from prnewswire.com

Avidity Biosciences to Participate in Upcoming Investor Conferences

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Stocks

Health Care

lsta

Lisata Therapeutics

NASDAQ: LSTA

+0.06 (+2.84%)

2.17

USD

At close at Sep 08, 18:10 UTC

Latest Cashu News

Lisata Therapeutics Eyes Uveal Melanoma Insights from Servier-IDEAYA Licensing Agreement

IDEAYA Biosciences Expands Team to Enhance Precision Oncology Initiatives, Boosting Stock Potential

Lisata Therapeutics: Imbed Biosciences Launches SAM™ PainGuard™ for Enhanced Wound Care Management